Amanda R Moore

7PUBLICATIONS

33CO-AUTHORS

Cancer geneticsPredictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 11, 2026

Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response.

|May 07, 2026

A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer.

|Apr 05, 2023

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.

Dan Li, Yu Zhan, Naitao Wang

|May 06, 2021

ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.

Ivana Yen, Frances Shanahan, Jeeyun Lee

|Nov 24, 2020

Combined Inhibition of Gα<sub>q</sub> and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.

Tyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo

|Oct 21, 2020

Author Correction: RAS-targeted therapies: is the undruggable drugged?

Amanda R Moore, Scott C Rosenberg, Frank McCormick

Pageof 2

Frequent Collaborators

3 joint publications

Yu Chen

2 joint publications

Frederic J de Sauvage

Robert Piskol

Shiva Malek

Emilie Ceraudo

Alexander N Shoushtari

Jasmine H Francis

Thomas P Sakmar

Jeeyun Lee

Sandra P Melo

Frequent Collaborators

3 joint publications

Yu Chen

2 joint publications

Frederic J de Sauvage

2 joint publications

Robert Piskol

2 joint publications

Shiva Malek